Payments for equipment utilization and the appropriateness of many emergency department scans will come under review by the Office of Inspector General under a fiscal year 2010 work plan.
Payments for equipment utilization and the appropriateness of many emergency department scans will come under review by the Office of Inspector General under a fiscal year 2010 work plan.
Every year the U.S. Department Health and Human Services Office of Inspector General (OIG) lists healthcare arrangements it believes cost too much or could violate federal fraud and abuse laws. Included in the 2010 OIG review is a look at the appropriateness of payments for x-rays performed in emergency departments.
OIG will also look at whether Medicare Part B payments reflect the actual expenses incurred by physicians and whether the utilization rate reflects current industry practices.
The Radiology Business Management Association recently published a study confirming actual equipment utilization is 54%, which is below the 75% called for in healthcare reform legislation from the House of Representatives.
Other projects include an ongoing examination of services and billing patterns in locations with a high density of independent diagnostic testing facilities.
"ACR members who render patient care in the areas listed in the work plan should not expect an immediate knock on their office door from the OIG," a press release from the American College of Radiology said. "However, it could happen, and to be prepared, radiologists and their staffs should properly document the medical necessity of and correct code for their services." Key elements of the work plan:
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.